ADAMTS1 and breast cancer: Other studies reported also that this drug inhibited both migration and invasion of breast cancer cells through the downregulation of thrombospondin-1 and the upregulation of its degrading protease ADAMTS1 (a disintegrin and metalloprotease with thrombospondin-1 motifs) [14].